InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,046.59
(
0.72%
)
US TECH 100
16,854.60
(
0.61%
)
Dow Jones
38,406.68
(
0.44%
)
Brent Oil
86.27
(
-0.16%
)
Bitcoin
66,546.65
(
-0.47%
)
BLOZF
Cannabix Technologies Inc
USOTC
Add Alert
Follow
329
BLOZF
Cannabix Technologies Inc
USOTC
Add Alert
Follow
329
Sticky
shell3
Outstanding: 114,144,104 for November 5, 2021

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up
Live Updating
Older
profile icon
smoki Free
04/22/24 11:28 PM
Post #27,498
Last Read
profile icon
shell3 Free
04/22/24 4:54 PM
Post #27,495
Last Read
profile icon
shell3 Free
04/22/24 11:13 AM
Post #27,493
Last Read
profile icon
smoki Free
04/16/24 1:33 PM
Post #27,492
Re: #27,491: @shell3 - Begins Certification of Contactless Alcohol Breathalyzer,
Last Read
profile icon
shell3 Free
04/16/24 11:04 AM
Post #27,491
Last Read
profile icon
shell3 Free
04/04/24 6:44 PM
Post #27,490
Last Read
profile icon
shell3 Free
04/03/24 4:55 PM
Post #27,489
Re: #27,488: @smoki - Dr Olla must be on the ball today!!
Last Read
profile icon
smoki Free
04/03/24 2:28 PM
Post #27,488
Last Read
profile icon
Fusiontech Free
04/02/24 9:25 AM
Post #27,487
Last Read
profile icon
Ragstoriches465 Free
04/01/24 6:49 PM
Post #27,486
Last Read
profile icon
shell3 Free
01/18/24 10:31 AM
Post #27,483
Bullish
Bullish
Last Read
profile icon
shell3 Free
01/03/24 9:10 AM
Post #27,479
Re: #27,478: @Carthnel - Patent filed check the mail !
Last Read
profile icon
shell3 Free
12/22/23 10:21 AM
Post #27,477
Bullish
Bullish
Last Read
profile icon
Carthnel Free
12/12/23 11:48 AM
Post #27,476
Re: #27,475: @shell3 - Outstanding: 114,144,104 for December 5, 2023
Last Read
profile icon
Energy Manager Free
11/08/23 11:11 AM
Post #27,474
Re: #27,473: @shell3 - Cannabix Completes Initial Electronics Testing on Contactless Alcohol
Last Read
profile icon
shell3 Free
11/07/23 12:11 PM
Post #27,473
Bullish
Bullish
Last Read
profile icon
FreezeThese Free
10/05/23 7:19 PM
Post #27,472
Last Read
profile icon
shell3 Free
10/05/23 4:51 PM
Post #27,471
Last Read
profile icon
smoki Free
10/05/23 12:55 PM
Post #27,470
Re: #27,469: @smoki - …current news from Algernon telling you plain as
Last Read
profile icon
smoki Free
10/05/23 12:53 PM
Post #27,469
Re: #27,468: @smoki - Lol … Shell, peace brother. Don’t see it.GLTY
Last Read
profile icon
smoki Free
10/04/23 10:35 PM
Post #27,468
Last Read
profile icon
shell3 Free
10/04/23 1:09 PM
Post #27,467
Last Read
profile icon
shell3 Free
10/04/23 12:46 PM
Post #27,466
Last Read
profile icon
smoki Free
09/11/23 3:52 PM
Post #27,462
Last Read
profile icon
smoki Free
09/07/23 9:48 PM
Post #27,461
Re: #27,459: @shell3 - That’s was a nice read and “Cannabix Technologies”
Last Read
profile icon
shell3 Free
09/05/23 10:13 PM
Post #27,460
Last Read
profile icon
shell3 Free
09/05/23 10:07 PM
Post #27,459
Re: #27,458: @smoki - ? Algernon pharma has not as of yet
Last Read
profile icon
smoki Free
09/05/23 11:25 AM
Post #27,458
Last Read
profile icon
smoki Free
08/26/23 3:21 PM
Post #27,455
Last Read
profile icon
shell3 Free
08/17/23 1:12 PM
Post #27,454
Re: #27,453: @smoki - FYI https://frascoprofiles.com/minnesota-updates-drug-testing-laws-cannabis-rest
Bullish
Bullish
Last Read
profile icon
smoki Free
08/05/23 12:48 AM
Post #27,451
Last Read
profile icon
shell3 Free
08/04/23 10:45 AM
Post #27,450
Bullish
Bullish
Last Read
Older

Cannabix Technologies Inc (BLOZF) RSS Feed

Followers
329
Posters
603
Posts (Today)
0
Posts (Total)
27498
Created
08/07/14
Type
Free
Moderators shell3





Cannabix Technologies Inc.

(CSE: BLO    US OTC: BLOZF    Frankfurt: 8CT:FRA)
 

Cannabix Technologies Inc. has
the exclusive North American license for
the Cannabix Marijuana Breathalyzer
from Cannabix Breathalyzer Inc.


Cannabix Technologies Inc. has
Worldwide Rights to
"Partial ovoidal FAIMS electrode"
Patent 8,237,118
from the University of Florida

WORLDWIDE RIGHTS
for 
CONTROLLED SUBSTANCE

Rights for 10 Years after 1st Product sold


What is FAIMS-MS?


It Blocks Out Unwanted Molecules
 Letting only THC Molecules Threw the Electrode
40 Minute Video with Dr Yost
https://www.msacl.org/index.php?header=Learning_Center&tab=Video_Management&subtab=Video_Request&id=8&conference=2015_US&type=plenary

 
Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana.  Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions.  Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing 


http://www.cannabixtechnologies.com/

 
Outstanding Shares
114,144,104
11/05/2021
 105,124,104
 10/06/2020
 
Cannabix Corporate Video
https://www.youtube.com/watch?v=ix3Uss9zrBo
Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc.  Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development.  Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.

Dr. Raj Attariwala, MD, PhD.,  Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).  Dr.  Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver.  He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products.  Dr.  Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.

Dr. Bruce Goldberger, PhD,  Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida.  Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.

Richard A. Yost Ph.D., Scientific Advisor

Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.

Jared Boock Ph.D, Principal investigator
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.

Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).

Rav Mlait, MBA – CEO, Director
.Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.

Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.


Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge. 

 
Andrew Davies,  Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.

Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016).  Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine. 




 
Volume:
Day Range:
Last Trade Time:
Delayed by 15 minutes
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Detailed Quote
BLOZF Latest News
More BLOZF News
New Post